Overall, patients with nucleolin expression (CD31hiNCLhi) had a higher risk of recurrence compared to patients with low tumor vessels (CD31loNCLlo) (HR = 2.768, 95% CI 1.544∼4.964, P = 0.001). Here, NUCLEOLIN is linked to neoplasm.